DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 4,165.00
+75.00 (1.83%)
At close: Oct 23, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 102.46 billion as of October 23, 2026. It is the 26,915th most valuable company in the world and the 1,240th biggest in South Korea. Its market cap has decreased by 11.51% in one year.
Market Cap
102.46B
Enterprise Value
91.83B
Revenue
73.28B
Global Rank
Country Rank
#1,240 South Korea
PE Ratio
340.72
ChartMarket Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 102.46B, a decrease of -38.01%. That is a compound annual growth rate of -7.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 102.46B | -32.52% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 1.07T |
| Penetrium Bioscience | 315.98B |
| HLB bioStep | 112.35B |
| P&K Skin Research Center | 49.10B |
| Kolmar BioTech | 34.84B |
| DT&CRO CO. | 27.42B |
| SLS BIO | 26.89B |
| C&R Research | 25.80B |